China Pharmaceutical Distribution Industry Report, 2013
  • Apr./2014
  • Hard Copy
  • USD $2,600
  • Pages:110
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: ALZ002
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,800

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of roughly 20% in 2005-2013. As the leading players in China’s pharmaceutical distribution industry, Shanghai Pharma, Jointown and China National Accord Medicines achieved the revenue of RMB58.1 billion , RMB24.8 billion , RMB15.8 billion, respectively, in the first three quarters of 2013.

In terms of drug categories, western medicine constitutes the first major category in Chinese medicine distribution market, accounting for approximately 70% of total revenue from Chinese pharmaceutical products during 2012-2013. Then what comes the next are Chinese patent medicine and traditional Chinese medicinal materials, which occupied 16.8% and 4.5%, respectively, of total revenue. In terms of distribution channels, the proportion of China's drug retail terminal and hospital terminal market share stood at 1:4.

The concentration of Chinese pharmaceutical distribution industry is relatively low. Take pharmaceutical chain market for example. In recent years, China's top 100 pharmaceutical chain enterprises have seen a rise in market share, but still less than 40%. In 2013, China's top 100 pharmaceutical chain enterprises posted a total of RMB98.36 billion in sales, up 11.9% from a year earlier. Guoda Drugstore under China National Accord Medicines still firmly held the first place in China's top 100 pharmaceutical chain enterprises, with the sales value for 2013 hitting RMB5.7 billion, a roughly 20% increase.

At present, Chinese pharmaceutical B2C sales model occupies a small market share in pharmaceutical terminal market, but grows rapidly. As of March 2014, a total of 235 companies in China have gained Qualification Certificate for Online Drug Trading Services, including 162 online pharmacies. In 2013, Chinese pharmaceutical B2C market presented the explosive growth, with transaction scale hitting RMB4.26 billion, up 166% from a year earlier. But due to policy restriction, consumers now fail to buy prescription drugs through pharmaceutical B2C, and medical insurance is not available, which would, to a certain extent, restrict the development of Chinese pharmaceutical B2C market.


China Pharmaceutical Distribution Industry Report, 2013-2017 involves the following:
20120114.gif?? Business model, operating environment, market size, sales structure, etc of Chinese drug distribution industry;
20120114.gif?? Stores, customers, sales structure and online pharmacies, etc of Top 100 Chinese drugstore chains;
20120114.gif?? Operation, profits, etc of 13 listed companies in Chinese pharmaceutical distribution industry.

1. Overview of Pharmaceutical Distribution Industry
1.1 Definition
1.2 Industry Chain
1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
1.3.1 Strength of Pharmaceutical Chain Enterprises
1.3.2 Weakness of Pharmaceutical Chain Enterprises

2. Development of China Pharmaceutical Distribution Industry
2.1 Pharmaceutical Distribution Industry
2.2 Industry Environment
2.2.1 China’s Healthcare Spending
2.2.2 China's Healthcare Organizations
2.2.3 Contribution of Pharmaceutical Distribution Industry to GDP, Taxation and Employment
2.3 Relevant Policies
2.4 Market Size
2.5 Development Structure
2.5.1 Sales Structure
2.5.2 Regional Structure
2.5.3 Ownership Structure
2.5.4 Distribution Structure

3. China’s Top 100 Pharmacy Chains 
3.1 Sales Scale
3.2 Store Analysis
3.2.1 Store Size
3.2.2 Sales per Unit Area
3.2.3 Pharmacies with Insurance Coverage
3.3 Consumer Analysis
3.3.1 Membership
3.3.2 Per Customer Transaction
3.3.3 Per Product Transaction
3.3.4 Average Sales Price
3.4 Classification 
3.4.1 Total Number of Drug Specifications
3.4.2 Prescription Drugs
3.4.3 OTC Drugs
3.4.4 Traditional Chinese Medicine Decoction Pieces
3.4.5 Medical Devices
3.4.6 Food/Health Care Products
3.4.7 Products with Private Brand or High Gross Profit
3.5 Single-store Analysis of Chinese Pharmacies 
3.6 Online Pharmacies
3.6.1 Scale of China Pharmaceutical B2C 
3.6.2 Characteristics of China Pharmaceutical B2C
3.6.3 Relevant Policies

4. Key Enterprises
4.1 China National Accord Medicines
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Major Clients
4.2 Nanjing Pharmaceutical Co., Ltd (NPC)
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Major Clients
4.3 Chongqing Tongjunge
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Major Clients
4.4 Shanghai No.1 Pharmacy
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Major Clients
4.5 China National Medicines
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Major Clients
4.6 Huadong Medicine
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Major Clients
4.7 Cachet
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Major Clients
4.8 Jointown
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Major Clients
4.9 Realcan Pharmaceutical
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Major Clients
4.10 Shanghai Pharma
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Gross Margin
4.10.5 Major Clients
4.11 Zhejiang Int’l Group
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Major Clients
4.12 Zhejiang Zhenyuan
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Major Clients
4.13 CNPIC
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Gross Margin
4.13.5 Major Clients

5. Summary and Forecast
5.1 Summary 
5.2 Forecast
China Pharmaceutical Distribution Channel
Difference between Pure Marketing and Allocation in China’s Pharmaceutical Distribution
Business Models of China Pharmaceutical Distribution Industry by Market
China’s Health Care Spending and % in GDP, 2000-2012
Health Spending of Government, Society and Individuals in China, 2000-2012
Percentage of Health Spending by Government, Society and Individuals in Total Health Spending in China, 2000-2012
Per Capita Health Spending of Urban and Rural Residents in China and % in Total Health Spending, 2005-2012
Number of Grass-Roots Medical and Health-Care Institutions, Professional Public Health Institutions and Hospitals in China, 2005-2012
Number and Growth Rate of Medical and Health-Care Institutions in China, 2005-2012
Policies on China Pharmaceutical Distribution Industry, 2006-2013
Sales Scale and Growth Rate of China Drug Distribution Industry, 2005-2013
Sales Scale and Growth Rate of Drug Retail Market in China, 2005-2012
Product Mix of China Pharmaceutical Distribution Industry, 2012
Sales Structure of China Pharmaceutical Distribution by Region, 2012
Revenue Structure of China Pharmaceutical Distribution by Ownership, 2012
Commodity Distribution Structure of Pharmaceutical Distribution Enterprises in China, 2012
Total Sales and Growth Rate of China Pharmaceutical Chains, 2007-2013
Sales Value and Growth Rate of China’s Top 100 Pharmacy Chains, 2003-2012
Sales Value and Ranking of Top 10 Enterprises, 2009-2012
Total Sales of Top 100 Pharmacies in China, 2007-2013
Number of Regular Chains of Top 100 Pharmacy Chains by Sales Value in China, 2011-2012
Number of Outlets of Top 100 Pharmacy Chains by Sales Value in China, 2011-2012
China’s Top 10 Pharmacy Chains by Number of Regular Chains and Number of Their Regular Chains, 2011-2012
China’s Top 10 Pharmacy Chains by Increment of Regular Chains and Number of Their Regular Chains, 2011-2012
China’s Top 10 Pharmacy Chains by Growth Rate of Regular Chains and Number of Their Regular Chains, 2011-2012
China’s Top 10 Pharmacy Chains by Daily Sales per Unit Area and Their Sales Value and Business Area, 2012
China’s Top 10 Pharmacy Chains by Daily Transaction in Unit Area and Their Transactions, 2012
China’s Top 10 Pharmacy Chains by Number of Pharmacies with Insurance Coverage and Number and Rate of Their Pharmacies with Insurance Coverage, 2012  
China’s Top 10 Pharmacy Chains by Rate of Pharmacies with Insurance Coverage and Number and Rate of Their Pharmacies with Insurance Coverage, 2012
China’s Top 10 Pharmacy Chains by Effective Members in Unit Area and Their Membership in Business Area and Unit Area, 2012
Proportions of Effective Members in Unit Area of Pharmacy Chains in China, 2011-2012
China’s Top 10 Pharmacy Chains by Proportions of Consumption by Members and Their Proportions, 2012
Proportions of Consumption by Members in Sales Value of China’s Pharmacy Chains, 2012
China’s Top 10 Pharmacy Chains by per Customer Transaction and Their per Customer Transaction, 2012
Per Customer Transaction Interval Distribution of China’s Pharmacy Chains, 2009-2012
China’s Top 10 Pharmacy Chains by per Product Transaction, Their per Customer Transaction, Quantity of Products and per Product Transaction, 2012
Per Customer Product Interval Distribution of China’s Pharmacy Chains, 2012
China’s Top 10 Pharmacy Chains by Average Quantity of Products and Their Average Quantity of Products, 2012
Average Quantity of Products Interval Distribution of China’s Pharmacy Chains, 2012
Sales Proportions of China’s Pharmacy Chains by Category, 2009-2012
Profit Source of China’s Pharmacy Chains
Profit Proportions of China’s Pharmacy Chains by Category, 2010-2012
China’s Top 10 Pharmacy Chains by Total Number of Drug Specifications and % of Total, 2012
China’s Top 10 Pharmacy Chains by Proportions of Sales Value from Prescription Drugs and % of Total, 2012
Percentage Distribution of Sales Value from Prescription Drugs in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Proportions of Profit from Prescription Drugs and % of Total, 2012
Percentage Distribution of Profit from Prescription Drugs in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Proportions of Sales Value from OTC Drugs and % of Total, 2012
Percentage Interval Distribution of Sales Value from OTC Drugs in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Proportions of Profit from OTC Drugs and % of Total, 2012
Percentage Distribution of Profit from OTC Drugs in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Sales Proportions of Traditional Chinese Medicine Decoction Piece Products and % of Total, 2012
Percentage Distribution of Sales Value from Traditional Chinese Medicine Decoction Piece Products in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Proportions of Profit from Traditional Chinese Medicine Decoction Piece Products and % of Total, 2012
Percentage Distribution of Profit from Traditional Chinese Medicine Decoction Piece Products in China’s Pharmaceutical Chain Industry, 2009-2012
Sales Percentage Distribution of Medical Device Products in China’s Pharmaceutical Chain Industry, 2009-2012
Percentage Distribution of Profit from Medical Device Products in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacy Chains by Proportions of Sales Value from Food/Health Care Products and % of Total, 2012
Percentage Distribution of Sales Value from Food/Health Care Products in China’s Pharmaceutical Chain Industry, 2010-2012
Top 10 Enterprises in China’s Pharmaceutical Chain Industry by Proportions of Profit from Food/Health Care Products and % of Total, 2012
Percentage Distribution of Profit from Food/Health Care Products in China’s Pharmaceutical Chain Industry, 2010-2012
Top 10 Enterprises in China’s Pharmaceutical Chain Industry by Number of Private Brands or Products with High Gross Margin, Their Quantity of Products and Number of Drug Specification, 2012
Quantitative Distribution of Private Brands or Products with High Gross Margin in China’s Pharmaceutical Chain Industry, 2009-2012
Top 10 Enterprises in China’s Pharmaceutical Chain Industry by Proportions of Private Brands or Products with High Gross Margin and % of Total, 2012
Percentage Distribution of Private Brands or Products with High Gross Margin in China’s Pharmaceutical Chain Industry, 2009-2012
China’s Top 10 Pharmacies in Single-Store Ranking List by Sales Value and Their Sales Value and Business Area, 2013
Top 10 Enterprises in China’s Pharmaceutical Chain Industry by B2C Sales Value and Their Sales Value, 2013
Distribution of Online Pharmacies in 2014Q1
Proportions of China’s Pharmaceutical B2C Market by Product, 2013
Revenue and Net Income of China National Accord Medicines, 2008-2013
Operating Revenue Structure of China National Accord Medicines by Product, 2009-2013
Revenue of China National Accord Medicines by Product, 2009-2013
Operating Revenue Structure of China National Accord Medicines by Region, 2008-2013
Revenue of China National Accord Medicines by Region, 2008-2013
Gross Margin of China National Accord Medicines, 2009-2013
China National Accord Medicines’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of NPC, 2008-2013
Operating Revenue Structure of NPC by Region, 2008-2013
Revenue of NPC by Region, 2008-2013
Operating Revenue Structure of NPC by Sector, 2008-2013
Revenue of NPC by Sector, 2008-2013
Gross Margin of NPC, 2008-2013
NPC’s Revenue from Major Clients and % of Total Revenue, 2008-2012
Revenue and Net Income of Chongqing Tongjunge, 2008-2013
Operating Revenue Structure of Chongqing Tongjunge by Region, 2008-2013 
Revenue of Chongqing Tongjunge by Region, 2008-2013
Operating Revenue Structure of Chongqing Tongjunge by Sector, 2008-2013 
Revenue of Chongqing Tongjunge by Sector, 2008-2013
Gross Margin of Chongqing Tongjunge in Pharmaceutical Industry, 2008-2013
Revenue of Chongqing Tongjunge from Major Clients and % of Total Revenue, 2008-2012
Revenue and Net Income of Shanghai No.1 Pharmacy, 2008-2013
Operating Revenue Structure of Shanghai No.1 Pharmacy by Sector, 2008-2013
Revenue of Shanghai No.1 Pharmacy by Sector, 2008-2013
Gross Margin of Shanghai No.1 Pharmacy, 2008-2013
Revenue of Shanghai No.1 Pharmacy from Major Clients and % of Total Revenue, 2008-2012
Revenue and Net Income of China National Medicines, 2008-2013
Operating Revenue Structure of China National Medicines by Region, 2009-2012
Revenue of China National Medicines by Region, 2009-2012 
Operating Revenue Structure of China National Medicines by Sector, 2008-2013
Revenue of China National Medicines by Sector, 2008-2013
Gross Margin of China National Medicines, 2008-2013
China National Medicines’ Revenue from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Huadong Medicine, 2008-2013
Operating Revenue Structure of Huadong Medicine by Region, 2008-2013
Revenue of Huadong Medicine by Region, 2008-2013
Operating Revenue Structure of Huadong Medicine by Product, 2008-2013
Revenue of Huadong Medicine by Product, 2008-2013
Gross Margin of Huadong Medicine, 2008-2013
Revenue of Huadong Medicine from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Cachet, 2008-2013
Operating Revenue Structure of Cachet by Region, 2009-2013
Revenue of Cachet by Region, 2009-2013
Operating Revenue Structure of Cachet by Product, 2008-2013
Revenue of Cachet by Product, 2008-2013
Gross Margin of Cachet, 2008-2013
Cachet’s Revenue from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Jointown, 2008-2013
Operating Revenue Structure of Jointown by Sector, 2008-2013
Revenue of Jointown by Sector, 2008-2013
Gross Margin of Jointown, 2008-2013
Jointown’s Revenue from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Realcan Pharmaceutical, 2008-2013
Operating Revenue Structure of Realcan Pharmaceutical by Region, 2008-2013 
Revenue of Realcan Pharmaceutical by Region, 2008-2013
Gross Margin of Realcan Pharmaceutical, 2008-2013
Revenue of Realcan Pharmaceutical from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Shanghai Pharma, 2008-2013
Operating Revenue Structure of Shanghai Pharma by Region, 2008-2013
Revenue of Shanghai Pharma by Region, 2008-2013
Operating Revenue Structure of Shanghai Pharma by Sector, 2010-2013
Revenue of Shanghai Pharma by Sector, 2010-2013
Gross Margin of Shanghai Pharma, 2008-2013
Revenue of Shanghai Pharma from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of Zhejiang Int’l Group, 2008-2013
Operating Revenue Structure of Zhejiang Int’l Group by Sector, 2010-2013
Revenue of Zhejiang Int’l Group by Sector, 2010-2013
Gross Margin of Zhejiang Int’l Group, 2008-2013
Revenue of Zhejiang Int’l Group from Major Clients, 2008-2013
Revenue and Net Income of Zhejiang Zhenyuan, 2008-2013 
Operating Revenue Structure of Zhejiang Zhenyuan by Region, 2008-2013
Revenue of Zhejiang Zhenyuan by Region, 2008-2013
Operating Revenue Structure of Zhejiang Zhenyuan by Sector, 2008-2013
Revenue of Zhejiang Zhenyuan by Segment, 2008-2013
Gross Margin of Zhejiang Zhenyuan, 2008-2013
Zhejiang Zhenyuan’s Revenue from Major Clients and % of Total Revenue, 2008-2013
Revenue and Net Income of CNPIC, 2008-2013
Operating Revenue Structure of CNPIC by Sector, 2011-2013
Revenue of CNPIC by Sector, 2011-2013
Gross Margin from Main Business of CNPIC, 2008-2013
Revenue of CNPIC from Major Clients and % of Total Revenue, 2008-2013
Sales Value and Growth Rate of China’s Top 100 Pharmacy Chains, 2003-2012
Sales Value, Profit and Growth Rate of Major Listed Pharmaceutical Chains in China, 2012-2013
Sales Scale of China’s Pharmaceutical Distribution Industry, 2011-2017E
Sales Scale of China’s Pharmaceutical Chain Industry, 2011-2017E

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号